Syndax Pharmaceuticals to Participate in Four Investor Conferences

• Syndax Pharmaceuticals CEO Michael A. Metzger and management will participate in four investor conferences in November 2026.
• Guggenheim 3rd Annual Healthcare Innovation Conference in Boston includes a fireside chat Nov. 10 at 11 a.m. ET.
• At the Stifel 2026 Healthcare Conference in New York, a fireside chat is scheduled for Nov. 12 at 9:20 a.m. ET.
• UBS Global Biopharma Conference 2026 in London features a fireside chat Nov. 17 at noon GMT/7 a.m. ET.
• The Jefferies London Healthcare Conference fireside chat takes place in London Nov. 19 at 12:30 p.m. GMT/7:30 a.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610300700PRIMZONEFULLFEED9856407) on October 30, 2026, and is solely responsible for the information contained therein.